Christiane E Angermann Selected Research

Adenosine Monophosphate (AMP)

7/2007

A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christiane E Angermann Research Topics

Disease

53	Heart Failure 04/2024 - 03/2003
7	Cardiomyopathies (Cardiomyopathy) 04/2024 - 10/2006
5	Systolic Heart Failure 01/2017 - 04/2007
4	Heart Diseases (Heart Disease) 07/2010 - 03/2004
3	Inflammation (Inflammations) 12/2009 - 03/2004
2	Fatigue 04/2019 - 06/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2012 - 02/2012
2	Chronic Disease (Chronic Diseases) 06/2011 - 01/2006
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2007 - 03/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2005 - 09/2003
2	Myocardial Infarction 07/2004 - 03/2003
2	Cardiomegaly (Heart Hypertrophy) 03/2004 - 09/2003
1	Weight Loss (Weight Reduction) 01/2023
1	Pulmonary Hypertension 12/2022
1	Acute Kidney Injury (Acute Renal Failure) 10/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Ischemia 01/2020
1	Atrial Fibrillation 04/2019
1	Neoplasms (Cancer) 01/2019
1	Mood Disorders (Mood Disorder) 12/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2018
1	Body Weight (Weight, Body) 06/2017
1	Death (Near-Death Experience) 01/2017
1	Muscle Weakness 06/2011
1	Edema (Dropsy) 02/2011
1	Hyperuricemia 02/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2011
1	Essential Hypertension 12/2009
1	Fibrosis (Cirrhosis) 12/2009
1	Immunoglobulin Light-chain Amyloidosis 03/2008
1	Amyloidosis 03/2008
1	Pathologic Constriction (Stenosis) 06/2007
1	Hypercholesterolemia 04/2007

Drug/Important Bio-Agent (IBA)

7	empagliflozinIBA 04/2024 - 01/2022
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2009
4	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2022
4	AutoantibodiesIBA 10/2023 - 10/2006
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 04/2007
4	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2022 - 01/2021
4	Natriuretic PeptidesIBA 06/2017 - 09/2004
3	DiureticsIBA 01/2023 - 02/2011
3	SodiumIBA 01/2021 - 04/2007
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 04/2007
2	Mineralocorticoid Receptor AntagonistsIBA 10/2023 - 04/2015
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023 - 01/2022
2	pro-brain natriuretic peptide (1-76)IBA 04/2019 - 09/2004
2	Bromocriptine (Parlodel)FDA LinkGeneric 09/2017 - 11/2015
2	ProlactinIBA 09/2017 - 11/2015
2	Escitalopram FDA Link 10/2016 - 06/2016
2	Serotonin (5 Hydroxytryptamine)IBA 06/2016 - 12/2007
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015 - 02/2011
2	Angiotensin Receptor AntagonistsIBA 04/2015 - 02/2011
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2015 - 04/2007
2	AldosteroneIBA 03/2015 - 04/2007
2	GoldIBA 08/2012 - 02/2012
2	Bronchodilator Agents (Bronchodilators)IBA 08/2012 - 02/2012
2	CholesterolIBA 02/2011 - 11/2009
2	NF-kappa B (NF-kB)IBA 09/2004 - 03/2003
2	p38 Mitogen-Activated Protein KinasesIBA 07/2004 - 09/2003
2	Proteins (Proteins, Gene)FDA Link 07/2004 - 03/2003
1	Furosemide (Lasix)FDA LinkGeneric 01/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	AntigensIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	SymportersIBA 01/2021
1	CreatinineIBA 01/2020
1	Uric Acid (Urate)IBA 04/2019
1	hydroxide ionIBA 04/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	LipidsIBA 01/2019
1	Docosahexaenoic AcidsIBA 01/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	Troponin IIBA 04/2017
1	NeuropeptidesIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	AdrenomedullinIBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 08/2016
1	AndrogensIBA 06/2011
1	Testosterone (Sustanon)FDA Link 06/2011
1	Procollagen Type IIBA 12/2009
1	procollagen Type III-N-terminal peptide (PIIP)IBA 12/2009
1	CollagenIBA 12/2009
1	Collagen Type I (Type I Collagen)IBA 12/2009
1	Collagen Type III (Type III Collagen)IBA 12/2009
1	Amyloid (Amyloid Fibrils)IBA 03/2008
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 03/2008
1	Prealbumin (Transthyretin)IBA 03/2008
1	ImmunosorbentsIBA 07/2007
1	EnzymesIBA 07/2007
1	AntibodiesIBA 07/2007
1	Adenosine Monophosphate (AMP)IBA 07/2007
1	Adenosine (Adenocard)FDA LinkGeneric 06/2007

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2006
9	Drug Therapy (Chemotherapy) 12/2023 - 09/2004
4	Patient Readmission 01/2023 - 09/2004
4	Micro-Electrical-Mechanical Systems 12/2022 - 11/2018
1	Length of Stay 10/2023
1	Ambulatory Care (Outpatient Care) 12/2019
1	Cognitive Training 08/2016
1	Heart Transplantation (Grafting, Heart) 11/2015